342 related articles for article (PubMed ID: 20599975)
1. Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.
Wills J; Jones J; Haggerty T; Duka V; Joyce JN; Sidhu A
Exp Neurol; 2010 Sep; 225(1):210-8. PubMed ID: 20599975
[TBL] [Abstract][Full Text] [Related]
2. Interaction between α-synuclein and tau in Parkinson's disease comment on Wills et al.: elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218.
Jellinger KA
Exp Neurol; 2011 Jan; 227(1):13-8. PubMed ID: 20965169
[TBL] [Abstract][Full Text] [Related]
3. Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.
Wills J; Credle J; Haggerty T; Lee JH; Oaks AW; Sidhu A
PLoS One; 2011 Mar; 6(3):e17953. PubMed ID: 21445308
[TBL] [Abstract][Full Text] [Related]
4. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.
Haggerty T; Credle J; Rodriguez O; Wills J; Oaks AW; Masliah E; Sidhu A
Eur J Neurosci; 2011 May; 33(9):1598-610. PubMed ID: 21453448
[TBL] [Abstract][Full Text] [Related]
5. Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease.
Kaul T; Credle J; Haggerty T; Oaks AW; Masliah E; Sidhu A
BMC Neurosci; 2011 Aug; 12():79. PubMed ID: 21812967
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammation and protein pathology in Parkinson's disease dementia.
Kouli A; Camacho M; Allinson K; Williams-Gray CH
Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
[TBL] [Abstract][Full Text] [Related]
7. Paraquat, but not maneb, induces synucleinopathy and tauopathy in striata of mice through inhibition of proteasomal and autophagic pathways.
Wills J; Credle J; Oaks AW; Duka V; Lee JH; Jones J; Sidhu A
PLoS One; 2012; 7(1):e30745. PubMed ID: 22292029
[TBL] [Abstract][Full Text] [Related]
8. Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.
Duka T; Duka V; Joyce JN; Sidhu A
FASEB J; 2009 Sep; 23(9):2820-30. PubMed ID: 19369384
[TBL] [Abstract][Full Text] [Related]
9. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
Duka V; Lee JH; Credle J; Wills J; Oaks A; Smolinsky C; Shah K; Mash DC; Masliah E; Sidhu A
PLoS One; 2013; 8(9):e75025. PubMed ID: 24073234
[TBL] [Abstract][Full Text] [Related]
10. High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
Bougea A; Stefanis L; Emmanouilidou E; Vekrelis K; Kapaki E
J Neural Transm (Vienna); 2020 Mar; 127(3):311-322. PubMed ID: 31912280
[TBL] [Abstract][Full Text] [Related]
11. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein modulates tau spreading in mouse brains.
Bassil F; Meymand ES; Brown HJ; Xu H; Cox TO; Pattabhiraman S; Maghames CM; Wu Q; Zhang B; Trojanowski JQ; Lee VM
J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33091110
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.
Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K
Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668
[TBL] [Abstract][Full Text] [Related]
14. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein.
Credle JJ; George JL; Wills J; Duka V; Shah K; Lee YC; Rodriguez O; Simkins T; Winter M; Moechars D; Steckler T; Goudreau J; Finkelstein DI; Sidhu A
Cell Death Differ; 2015 May; 22(5):838-51. PubMed ID: 25394490
[TBL] [Abstract][Full Text] [Related]
15. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
[TBL] [Abstract][Full Text] [Related]
16. Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia.
Kotzbauer PT; Cairns NJ; Campbell MC; Willis AW; Racette BA; Tabbal SD; Perlmutter JS
Arch Neurol; 2012 Oct; 69(10):1326-31. PubMed ID: 22825369
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
18. Rotenone Induces a Neuropathological Phenotype in Cholinergic-like Neurons Resembling Parkinson's Disease Dementia (PDD).
Giraldo-Berrio D; Mendivil-Perez M; Velez-Pardo C; Jimenez-Del-Rio M
Neurotox Res; 2024 Jun; 42(3):28. PubMed ID: 38842585
[TBL] [Abstract][Full Text] [Related]
19. Striatal beta-amyloid deposition in Parkinson disease with dementia.
Kalaitzakis ME; Graeber MB; Gentleman SM; Pearce RK
J Neuropathol Exp Neurol; 2008 Feb; 67(2):155-61. PubMed ID: 18219254
[TBL] [Abstract][Full Text] [Related]
20. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex.
Winton MJ; Joyce S; Zhukareva V; Practico D; Perl DP; Galasko D; Craig U; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 May; 111(5):401-12. PubMed ID: 16609851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
